Compare KLTR & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KLTR | CNXU |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 215.9M |
| IPO Year | 2021 | 2025 |
| Metric | KLTR | CNXU |
|---|---|---|
| Price | $1.60 | $7.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 225.2K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,854,000.00 | N/A |
| Revenue This Year | $2.96 | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $1.06 | $6.85 |
| 52 Week High | $2.05 | $13.66 |
| Indicator | KLTR | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 40.41 |
| Support Level | $1.56 | N/A |
| Resistance Level | $1.68 | $10.77 |
| Average True Range (ATR) | 0.08 | 1.08 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 38.02 | 9.83 |
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.